Establishment License Issued for Third Green Spirit RX Medicinal Cannabis Dispensary by Department of Health of Puerto Rico

June 6, 2018

Third Puerto Rico Green Spirit RX Dispensary to Begin Operations in Hato Rey Neighborhood of San Juan

DORADO, Puerto Rico, June 06, 2018 (GLOBE NEWSWIRE) -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has been issued the requisite establishment license by the Department of Health of Puerto Rico (“DHPR”) to commence operations of the Company’s third Puerto Rico medicinal cannabis dispensary, which is located in the Hato Rey neighborhood of San Juan.

Green Spirit’s newest dispensary is located at Calle César González #508, Hato Rey, Puerto Rico 00918, a heavily trafficked area that is in close proximity to a large concentration of medical facilities, most notably Clinica las Americas Medical Center and El Maestro Hospital. San Juan‘s Hato Rey district includes a mix of both residential and commercial properties and is the city’s most densely populated district. Green Spirit currently operates a Green Spirit RX dispensary located in the Paseo del Plata Shopping Center, Building No. 3, P.R. 696, int. José Efrón Avenue, Dorado, Puerto Rico, along with The Green Room, a full-service (medicinal and recreational) cannabis dispensary business located at 138 Main Street in Point Arena, Mendocino County, California.

The Company anticipates completing construction at its other locations in Puerto Rico during 2018, with operations commencing thereafter upon receipt of the requisite operating permits from the DPR.

For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.

About Green Spirit Industries Inc.Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products.

Forward-Looking StatementsThis press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact: Paul GendreauPGPR paul@pgprmedia.com 678-807-7945

Update hourly